KR100375047B1 - Health beverage containing naringin and naringenin used for acceleration of alcohol metabolism - Google Patents

Health beverage containing naringin and naringenin used for acceleration of alcohol metabolism Download PDF

Info

Publication number
KR100375047B1
KR100375047B1 KR10-2000-0002813A KR20000002813A KR100375047B1 KR 100375047 B1 KR100375047 B1 KR 100375047B1 KR 20000002813 A KR20000002813 A KR 20000002813A KR 100375047 B1 KR100375047 B1 KR 100375047B1
Authority
KR
South Korea
Prior art keywords
alcohol
naringin
naringenin
group
present
Prior art date
Application number
KR10-2000-0002813A
Other languages
Korean (ko)
Other versions
KR20010075892A (en
Inventor
오광석
조정일
Original Assignee
오광석
조성동
차월석
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오광석, 조성동, 차월석 filed Critical 오광석
Priority to KR10-2000-0002813A priority Critical patent/KR100375047B1/en
Publication of KR20010075892A publication Critical patent/KR20010075892A/en
Application granted granted Critical
Publication of KR100375047B1 publication Critical patent/KR100375047B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/334Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts

Abstract

본 발명은 citrus aurantium에서 추출한 naringin과 상기와 같이 추출한 naringin을 2% 황산(H2SO4)으로 가수분해(hydrolysis)하여 얻은 naringenin을 각각 또는 그 혼합물을 유효성분으로 함유함을 특징으로 하는 알코올 대사촉진을 위한 건강음료조성물에 관한 것이다.Alcohol metabolism of the present invention comprises naringin extracted from citrus aurantium and naringenin obtained by hydrolysis of 2% sulfuric acid (H 2 SO 4 ) as described above or a mixture thereof as an active ingredient. It relates to a health beverage composition for promotion.

본 발명의 건강음료조성물은 알코올 음용에서 생성되는 주요 독성물질인 아세트알데하이드 생성과정에서 소모된 NAD를 NADH로부터 빨리 재생시켜 줌으로써 알코올 분해를 촉진시킴은 물론 알코올 음용시 발생하는 다량의 활성산소를 극도로 억제시킴으로써 알코올성 장애를 보호해주는 효과가 있다. 또한, 본 발명의 건강음료조성물에는 헤스페리딘, 헤스페레틴, 비타민류, 아미노산류, 미네랄류, 당류, 유기산류 및 추출천연약용식물을 필요에 따라 추가로 첨가할 수 있다.The health beverage composition of the present invention promotes alcohol decomposition by rapidly regenerating NAD consumed in the process of producing acetaldehyde, which is a major toxic substance produced in alcohol drinking, from NADH, as well as extremely high amounts of free radicals generated during alcohol drinking. By suppressing it has the effect of protecting alcoholic disorders. In addition, hesperidin, hesperetin, vitamins, amino acids, minerals, sugars, organic acids and extracts of natural extracts can be added to the health beverage composition of the present invention as needed.

Description

나린진 또는 나린게닌을 유효 성분으로 함유하는 알코올대사 촉진을 위한 건강음료조성물{Health beverage containing naringin and naringenin used for acceleration of alcohol metabolism}Health beverage containing naringin and naringenin used for acceleration of alcohol metabolism}

본 발명은 citrus aurantium에서 추출한 naringin과 상기와 같이 추출한 naringin을 2% 황산(H2SO4)으로 가수분해(hydrolysis)하여 얻은 naringenin을 각각 또는 그 혼합물을 유효성분으로 함유함을 특징으로 하는 알코올 대사촉진을 위한 건강음료조성물에 관한 것이다.Alcohol metabolism of the present invention comprises naringin extracted from citrus aurantium and naringenin obtained by hydrolysis of 2% sulfuric acid (H 2 SO 4 ) as described above or a mixture thereof as an active ingredient. It relates to a health beverage composition for promotion.

본 발명의 건강음료조성물에는 헤스페리딘, 헤스페레틴, 비타민류, 아미노산류, 미네랄류, 당류, 유기산류 및 추출천연약용식물을 필요에 따라 추가로 첨가할 수 있다. 또한, 본 발명의 다른 실시양태로는 naringin이나 naringenin을 각각 또는 혼합된 것을 야채, 과일즙 혹은 쥬스에 첨가하거나 해조류 추출물에 첨가하여 제조할 수 있고, 구취(口臭), 땀냄새(汗臭)등의 제거 및 탈취제의 원료로 효과가 있어 이용되고 있는 증류 발효된 목초액에 첨가하여 제조할 수 있는데, 통상 증류 목초액(Distilled pyroligneous liquor)은 초기에 취득된(흑탄요에서 목초액의 수량은 탄재의 중량에 대하여 5%이고 목탄의 수량에 대하여 약 1/3이며, 흑탄 목초액의 산도는 3.5-4.0이고, 백탄 목초액의 산도는 비중이 3.3인 경우 7이다.) 목초액을 증류하면 용해타르(Dissolved tar)가 제거되어 황색 또는 소맥색의 증류 목초액으로 되며, 이때 소량의 황산을 가해 증류하면 용해타르 및 페놀류와 알데하이드와의 축합에 의해 생성된 수지와 고온에 의해 증축합된 물질이 완전히 제거된 증류 목초액이 얻어지며, 이와같이 취득된 목초액을 식품가공 및 구취, 땀냄새등을 제거하는 용도로 이용할 수 있으며, 3개월이상 숙성 발효시킨 다음에도 사용할 수 있다.Hesperidin, hesperetine, vitamins, amino acids, minerals, sugars, organic acids and extracts of natural extracts can be added to the health beverage composition of the present invention as needed. In another embodiment of the present invention, naringin or naringenin may be prepared by adding each or a mixture to vegetables, fruit juices or juices or to seaweed extracts, and bad breath, sweating, and the like. Can be prepared by adding to distilled fermented wood vinegar, which is effective as a raw material of deodorant and deodorant. Generally, distilled pyroligneous liquor is obtained initially (in black charcoal, the quantity of wood vinegar is based on the weight of carbon ash). 5%, about 1/3 of the quantity of charcoal, the acidity of black charcoal vinegar is 3.5-4.0, and the acidity of white charcoal vinegar is 7 when specific gravity is 3.3.) It is removed to give a yellow or wheat distilled wood vinegar, in which a small amount of sulfuric acid is added to distill the resultant, which is condensed by high temperature with a resin produced by condensation of dissolved tar and phenols with aldehyde. Distilled wood vinegar is obtained from which the substance has been completely removed. The obtained wood vinegar can be used for the purpose of processing food, removing bad breath, and smelling sweat. It can also be used after fermentation for at least 3 months.

본 발명의 건강음료조성물은 알코올과음으로 초래되는 숙취 및 알코올성 질환을 경감 또는 해소, 예방하는데 현저한 효과가 있다. 알코올성 대사 생리활성을 위해서 장기적으로 섭취하는 것도 효과가 있으나 최대의 효과를 얻기 위해서는 알코올섭취 30분 전에 투여하거나, 음주후 30분 이내에 투여하는 것이 효과적이다.The health beverage composition of the present invention has a remarkable effect in reducing or eliminating or preventing hangovers and alcoholic diseases caused by alcohol drinking. Long-term intake is also effective for alcoholic metabolic physiological activity, but to obtain the maximum effect it is effective to administer 30 minutes before alcohol intake or within 30 minutes after drinking alcohol.

본원 발명의 유효성분인 naringin과 naringenin에 대한 추출 및 안전성에 대해서는 여러보고가 있다.There are several reports on the extraction and safety of naringin and naringenin, the active ingredients of the present invention.

상기 화학식 1로 표시되는 Naringin은 7-[{2-Ο-(6-Deoxy- α-L-mannopyranosyl)-β-D-glucopyranosyl}-2,3-dihydro-5-hydroxy-2-(4-hydroxypheny)-4H-1-benzopyran -4-one; 4',5,7-trihydroxyflavonone7-rhmnoglucoside; naringenin-7-rhmnogluco side, aurantiin.으로 분자식은 C27H32O14: mol wt 580.54, C 55.86%, H 5.56%, O 38.58%로 구성되어 있으며, 고미성(苦味性)의 무색(無色) 결정(結晶)의 flavonon의 glucoside다.Naringin represented by Chemical Formula 1 is 7-[{2-Ο- (6-Deoxy-α-L-mannopyranosyl) -β-D-glucopyranosyl} -2,3-dihydro-5-hydroxy-2- (4- hydroxypheny) -4H-1-benzopyran -4-one; 4 ', 5,7-trihydroxyflavonone 7-rhmnoglucoside; naringenin-7-rhmnogluco side, aurantiin.The molecular formula consists of C 27 H 32 O 14 : mol wt 580.54, C 55.86%, H 5.56%, O 38.58%, and is a highly odorless colorless. It is the glucoside of crystalline flavonon.

Naringin의 aglucon인 상기 화학식 2로 표시되는 Naringenin은 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 4',5,7-trihydroxyfl avonone; naringetol; pelargidanon 1602.으로 naringin의 가수분해(hydrolysis of naringin)에 의해 취득되며 고미성(苦味性)이 아니며 그 분자식은 C15H12O5이며 mol wt 272.26, 그 구성은 C 66.17%, H 4.44%, O 29.38%이며, 황색결정이다.Naringenin represented by Formula 2, which is an aglucon of Naringin, may be selected from the group consisting of 2,3-Dihydro-5,7-dihydroxy-2- (4-hydroxyphenyl) -4H-1-benzopyran-4-one; 4 ', 5,7-trihydroxyfl avonone; naringetol; obtained by the hydrolysis of naringin as pelargidanon 1602. It is not highly crystalline and its molecular formula is C 15 H 12 O 5 , mol wt 272.26, its composition is C 66.17%, H 4.44%, O 29.38%, yellow crystals.

Naringin의 추출은 천연자원으로 menthalongifolia, vernoniabrevifolia, zanthoxylumavicenae, zanthoxylum dipetalum, fortunella margarita, eremocitrus glauca, cylmenia olyandra, fortunella japonica F margartia등에서 추출한 보고가 있으나, 지금까지 가장 많은 추출보고자료는 쥐손이풀목(geraniales)의 운향과(rutaceae)에 속하는 citrus fruits에서 나타나고 있다. citrus fruits에 속하는 천연물로는 orange, lemon, lime, grafe fruit, citrus aurantium, citrus grandis, citrus junos, citrus unshiu marcor, citrus kinokuni tanaka 등으로 세계 도처에서 볼 수 있는 풍부한 자원으로 그 열매는 식용으로 활용하고 있다.Naringin has been extracted from natural sources such as menthalongifolia, vernoniabrevifolia, zanthoxylumavicenae, zanthoxylum dipetalum, fortunella margarita, eremocitrus glauca, cylmenia olyandra, and fortunella japonica F margartia. It is found in citrus fruits belonging to the rutaceae family. Natural products belonging to citrus fruits include orange, lemon, lime, grafe fruit, citrus aurantium, citrus grandis, citrus junos, citrus unshiu marcor and citrus kinokuni tanaka. have.

지금까지 추출 보고된 자료는 아래와 같다.The data reported so far are as follows.

MAtsuno(일본:1958)와 Kefford(미국:1958)는 식물의 성분 분류학적 연구에서 naringin군과 hesperidin군으로 분류 추출하였고, Horowitz(미국:1961) neohesperidoside군과 rutinoside로 분류하였으며, Nishiura,M(일본:1969)은 citrus kinokuni tanaka에서 flavonoid계 성분을 검색하여 hesperidin군과 neohesperetin, naringin군과 isonaringin군으로 분류하였다.MAtsuno (Japan: 1958) and Kefford (USA: 1958) were extracted and classified into naringin and hesperidin groups in the plant taxonomic studies, Horowitz (1961), neohesperidoside and rutinoside, and Nishiura, M (Japan). (1969) searched for flavonoids in citrus kinokuni tanaka and classified them into hesperidin, neohesperetin, naringin and isonaringin groups.

Kamiya.s(일본:1971)등은 flavonoid 성분 조합에 준하여 rutinoside와 neohesperidoside로 대별하고 있으며, Poor,H.D(영국: 1934) 및 Shijuo .H(일본:1952)는 citrus aurantium의 꽃에서 Takao.M(일본:1959)는 citrus medicavar sarcodaectylus의 과피에서, Masanobu.k(일본:1952)등은 citrus natsudaidai의 츄스에서, 한국에서는 Kim.C.M(1979)등이 당유자, 지귤, 하귤등의 엽과 과피 및 수피에서 naringin을 비롯한 flavonoid성분 pattern을 비교 검색한바 있으며, 병귤의 과피에서 각각 naringin을 단리 보고한 바 있다.Kamiya.s (Japan: 1971) is divided into rutinoside and neohesperidoside according to the flavonoid component combination, and Poor, HD (UK: 1934) and Shijuo.H (Japan: 1952) are Takao.M (from the flowers of citrus aurantium). Japan: 1959) is the skin of citrus medicavar sarcodaectylus, Masanobu.k (Japan: 1952) is citrus natsudaidai's chew, and in Korea, Kim.CM (1979) is the leaves and skin of sugar, citrus, and mandarin In the bark, naringin and flavonoid component patterns were compared and searched, and naringin was isolated from the peel of bottled orange.

Yusof . S(말레이지아 :1990)는 말레이시아산 citrus fruits에서 naringin을 추출하였다는 보고를 한 바 있다. 또한, Naringenin에 대해 Asahina, imnbuse(BER, 1928년)와 Haley, Bassin, J(AM, 1951년)등이 naringin의 가수분해에 의해서 취득한 보고가 있으며, Rosenmund(BER)와 Zemplen, Bognar(ber)등은 1928년과 1942년에 각각 합성을 보고한 바 있다. 그후 꾸준히 연구되어 최근에는 미국, 일본, 독일, 이스파니아등에서 보고되고 있으며, 우리나라에서도 꾸준한 연구보고가 이루어지고 있다.Yusof. S (Malaysia: 1990) reported the extraction of naringin from citrus fruits from Malaysia. In addition, as reported by Asahina, imnbuse (BER, 1928) and Haley, Bassin, J (AM, 1951) for naringenin, hydrolysis of naringin is reported. Rosenmund (BER), Zemplen, Bognar (ber) Et al. Reported synthesis in 1928 and 1942, respectively. Since then, it has been steadily researched and recently reported in the United States, Japan, Germany, Spain, etc., and a steady research report in Korea.

은종방(한국:1996)등은 citrus fruits의 과육과 과피에서 naringin의 검색을 보고한 바 있다. naringin과 naringenin의 안전성 및 항균력에 대한 연구 보고된 자료를 보면, Wilson.R.H(미국 : 1940)등은 rat에 1% naringin을 함유한 시료를 200일간 경구 투여하였을 때 성장 및 장기 중량에 영향이 없었으며, 또한 Garino(미국:1981)는 naringin을 개에 경구 투여 또는 비경구 투여시 뇨로 배설되어 독성이 될 수 있는 증상을 발견할 수 없다는 보고를 한 바 있으며, Han.S.S. and you,I,J(한국: 1988)등은 naringin의 안전성에 관한 연구에서 혈액 임상학적, 병리조직학적 검사에 있어서 모두 안전성이 있는 것으로 보고하고 있으며, Eo.s.k. Lee.j.h (한국:1997)등은 HSV(Herpes Simplex virus)에 대한 바이러스 억제 효과 실험보고에서 naringin, naringenin이 우수한 항 바이러스 효과가 있음을 보고한 바가 있다. 또한, L.c.k. Han.s.s등(한국 1996)은 naringin과 naringenin 의 항균력 시험 보고에서 항균력이 뛰어남을 보고한 바 있으며, naringin의 비 배당체인naringenin과 병용 투여시 뛰어난 항균력의 상승 효과를 보고하고 있다.Eun Jong-bang et al. (Korea: 1996) reported the search of naringin in the pulp and skin of citrus fruits. Studies on the safety and antimicrobial activity of naringin and naringenin reported that Wilson.RH (USA: 1940) had no effect on growth and organ weight when oral administration of a sample containing 1% naringin in rats for 200 days. Garino (USA: 1981) also reported that naringin could not be found to be toxic by excretion of urinary oral or parenteral naringin in dogs. Han.SS and you, I, J (Korea: 1988) reported that the safety of naringin is safe for both clinical and pathological examinations of blood and Eo.s.k. Lee.j.h (Korea: 1997) and others reported that naringin and naringenin have excellent antiviral effects in the experimental report of the virus inhibition effect against HSV (Herpes Simplex virus). In addition, L.c.k. Han.s.s et al. (Korea, 1996) reported an excellent antimicrobial activity in naringin and naringenin antibacterial test reports, and reported a synergistic effect of naringin in combination with the non-glycoside of naringin.

알코올의 대사 및 배설에 관한 기전Mechanisms on metabolism and excretion of alcohol

술은 동서양을 막론하고 우리 인간과 땔 수 없는 가장 긴밀한 기호음료였다. 알맞게 먹은 술은 인체의 신진대사를 도와 건강을 유지하는데 이로움을 준다. 그러나, 과도한 음주는 신체적인 면 뿐만 아니라 정신적인 면에도 악영향을 미쳐 심각한 질병을 유발시키기 마련이다. 예를 들면, 알코올성 간 질환(간경변,지방간,간암)을 일으키거나, 피로축적(lactate축적), 저혈당증(hyperglycemia), 알코올성간염(alcholic gout), 기억력감퇴, 집중력감소, 감수성저하등 갖가지 병변증 현상을 일으켜 심하면 사망에 이르게도 할 뿐만 아니라 불안과 긴장을 고조시켜 항상 알코올에 의존하게 함으로써 건전한 사회생활을 지속하기 어렵게 함으로써 마침내 사회로부터 고립상태에도 빠질 수 있다.Liquor was the closest taste drink incomparable with our human beings in both East and West. Properly eaten alcohol helps the body's metabolism to help maintain health. However, excessive drinking can adversely affect not only the physical but also the mental, causing serious illness. For example, alcoholic liver disease (liver cirrhosis, fatty liver, liver cancer), fatigue accumulation (lactate accumulation), hypoglycemia (hyperglycemia), alcoholic hepatitis (alcholic gout), memory loss, concentration concentration, sensitivity to various lesions This can lead to death, as well as heighten anxiety and tension, so that it is always dependent on alcohol, making it difficult to sustain a healthy social life, which can eventually lead to isolation from society.

술은 물과 에탄올이 주성분이며 나머지는 컨저너라고 한다. 컨저너는 감미료, 향료, 당분, 단백질, 미네랄 등이다. 여러 종류의 술을 섞어먹는다고 해서 알코올의 대사과정이나 대사량이 변화하는 것은 아니다. 그러나, 섞어 마시면 여러 술속에 섞여있는 컨저너들이 서로 반응해 간의 알코올대사과정을 교란시키므로 숙취가 심해지며 오래간다. 또한, 시판되고있는 주종에 따라 숙취의 정도가 달라진다. 예를 들어, 15°-30°의 알코올 도수를 가진 술이 가장 빨리 흡수된다. 따라서, 맥주(4%)나 양주(40%)보다 소주(15°-25°), 청주(10°-15°)에 더 빨리 취하게 된다. 삼페인같이 탄산가스가 발생하는 술은 그렇지 않은 술 보다도 더 빨리 취한다. 탄산가스가 위벽을 자극해 위의 알코올 흡수 기능을 향상시키기 때문이다.막걸리는 도수는 낮지만 정제되지 않은 다양한 컨저너가 위벽에 오래도록 달라붙어 있어 취기가 오래간다.Alcohol is mainly composed of water and ethanol, and the rest is called a conditioner. Conditioners include sweeteners, flavorings, sugars, proteins and minerals. Mixing different types of alcohol does not change the metabolism or metabolic rate of alcohol. However, if you mix and drink, the various blenders in the alcohol will react with each other and disturb the liver metabolism process, so the hangover becomes longer and lasts longer. In addition, the degree of hangover varies depending on the type of commercially available. For example, alcohol with an alcohol content of 15 ° -30 ° is absorbed fastest. Therefore, it is faster to drink (15 ° -25 °) and sake (10 ° -15 °) than beer (4%) or liquor (40%). Alcohols that produce carbon dioxide, like champagne, are drunk faster than alcohol that does not. This is because carbon dioxide stimulates the stomach wall and improves the absorption of alcohol in the stomach, which has a low frequency but a variety of unrefined containers stick to the stomach wall for a long time.

알코올대사는 주로 간에서 일어나며 ZN을 함유한 ADH(Alcohol Dehydro genase)에 의해 Acetaldehyde로 대사되며 이에는 NAD(Nicotinamide Adenine dinucleotide)를 필요로 한다. ADH에 의한 반응은 영차역학(zero order kinetics)에 의하여 이루어지며 그 반응속도는 일정하다.Alcohol metabolism occurs mainly in the liver and is metabolized to Acetaldehyde by ZH-containing alcohol dehydro genase (ADH), which requires nicotinamide adenine dinucleotide (NAD). The reaction by ADH is accomplished by zero order kinetics and the reaction rate is constant.

Acetaldehyde는 Aldehyde dehydrogeanse에 의하여 Acetic Acid로 변화되며 이 단계에서도 NAD를 필요로 한다. 이 반응은 대단히 빨라서 대량의 알코올을 섭취하더라도 혈중 AcetAldehyde의 농도는 극히 낮다. 생성된 Acetate는 다시 AcetylCoenzyme A로 변환되어 TricarboxylAcid(TCA) cycle로 들어와서 CO2와 H2O로 산화된다.Acetaldehyde is converted to Acetic Acid by Aldehyde dehydrogeanse, which also requires NAD. This reaction is so fast that even when you drink a lot of alcohol, the concentration of AcetAldehyde in your blood is extremely low. The produced Acetate is converted back into AcetylCoenzyme A, enters the TricarboxylAcid (TCA) cycle and is oxidized to CO 2 and H 2 O.

알코올이 산화됨에 따라 ADH:NAD 비율이 증가하므로 부수적인 유산 및 지방산 생성, 혈중 요산의 증가가 나타난다. 따라서, NAD는 알코올 대사과정에서 속도제한 요소이며 NAD 공급을 증가시키면 알코올대사는 빨라질 수 있다.As the alcohol is oxidized, the ADH: NAD ratio increases, resulting in ancillary lactic acid and fatty acid production and an increase in blood uric acid. Thus, NAD is a rate limiting factor in alcohol metabolism and alcohol metabolism can be accelerated by increasing NAD supply.

ADH는 간장 이외에 위 점막에도 존재한다고 밝혀졌다. 위점막 ADH 활성은 간장에 비하여는 매우 낮으나 위점막 ADH는 혈액으로 흡수되는 알코올의 양 즉 알코올의 생체내 유용도(Bio Availability)를 저하시킨다. 섭취한 알코올의 대부분은 산화되어 대사되므로 대사되지 않고 배설되는 양은 섭취하는 양의 2%, 대량 섭취하는 경우라도 10% 미만이다. 대사되지 않은 알코올은 땀 및 소화선 분비, 소변 등을통해 그대로 배설되며 소변이 주된 배설 경로이다. 따라서, 술에 취한 후 땀을 흘리거나 이뇨제를 복용하는 것은 술에서 빨리 깨게하는데 별 도움을 주지 못한다. 혈중 알코올 농도가 0.3%이더라도 소변 1000ml로 배설되는 알코올량은 약 3g으로 맥주100ml 에 함유된 알코올 용량에도 미치지 못한다. 따라서, 알코올에 의한 급성 독성은 Ethylalcohol, AcetAldehyde 및 알코올대사 산물의 변형 생성 물질등에 기인한다고 보고되고 있다. 그래서, 알코올 섭취후 혈중 알코올 농도를 낮추는 것은 음주에 의한 급성중독상태에 머무는 시간을 단축시키는 데 실제적인 중요성이 있다고 볼 수 있는 것이다.ADH has also been shown to be present in the gastric mucosa in addition to the liver. Gastric mucosal ADH activity is very low compared to liver, but gastric mucosal ADH decreases the amount of alcohol absorbed into the blood, ie, the bioavailability of alcohol. Most of the ingested alcohol is oxidized and metabolized, so the amount that is not metabolized is excreted less than 2% of the intake amount, even in large quantities less than 10%. Unmetabolized alcohol is excreted intact through sweat, digestive glands, and urine, and urine is the main route of excretion. Therefore, sweating after taking alcohol or taking diuretics does not help you to wake up quickly. Even if the blood alcohol concentration is 0.3%, the amount of alcohol excreted in 1000 ml of urine is about 3 g, which is less than the alcohol content in 100 ml of beer. Therefore, it is reported that acute toxicity by alcohol is due to modified products of Ethylalcohol, AcetAldehyde and alcohol metabolites. Therefore, lowering the alcohol level after alcohol consumption can be regarded as a practical importance in shortening the time spent in acute poisoning by drinking.

지금까지 알려진 바로는 숙취의 주 메카니즘을As far as is known, the main mechanism of hangover

첫째: 숙취는 알코올 음용으로 생성되는 아세트알데히드가 주요 독성물이며, 둘째: 알코올대사 과정에서 활성산소가 다량으로 발생하여 이들이 알코올성 장애를 초래하는 주요 원인이다.First, hangover is the major toxic substance produced by alcohol drinking, and second: the major cause of alcoholic disorders is the large amount of free radicals generated during alcohol metabolism.

또한, 알코올이 인체에 흡입되면 다음과 같은 3가지 경로를 통해 산화되는데, 첫째: 간과 위장관에 존재하는 ADH(AlcoholDehydrogenase)와 ALDH (AldehydeDehydrogenase)의 작용의 경로, 둘째: MEOS에 의해서 이루어지는 경로(소포체에 존재하는 microsomal ethanol oxidation system :meos), 셋째: Peroxysome에 존재하는 Catalase라는 enzyme(효소)의 작용등을 거쳐 CO2와 H2O로 분해된다.In addition, when alcohol is inhaled into the human body, it is oxidized through the following three pathways. Microsomal ethanol oxidation system (meos) present, and third: Catalase in the peroxysome through the action of the enzyme (enzyme), such as decomposition of CO 2 and H 2 O.

이와 같은 과정을 도식화하면,Schematic of this process,

(과정Ⅰ)Course I

분해된다. Decompose

에칠알코올이 알코올탈수소효소(ADH)와 보조효소인 니코틴산아미드 아데닌 디뉴클레오티드(NAD)에 의해 AcetAldehyde로 대사되고, 알데하이드탈수소 효소(ALDH)와 NAD의 환원된 니코틴산아미드아데닌 디뉴클레오티드(NADH)로의 변환이 이루어지며 여기에 이들 효소들의 작용에 의하여 아세트알데하이드는 아세트산(Acetic Acid)으로 변환됨과 동시에 이것들이 물과 탄산가스로 전환된다.Ethyl alcohol is metabolized to AcetAldehyde by alcohol dehydrogenase (ADH) and coenzyme nicotinic acid adenine dinucleotide (NAD), and the conversion of aldehyde dehydrogenase (ALDH) and NAD to reduced nicotinic acid amide adenine dinucleotide (NADH) By the action of these enzymes, acetaldehyde is converted into acetic acid and at the same time they are converted into water and carbon dioxide.

과정을 보다 구체화 시키면,If you refine the process,

(과정Ⅱ)Course II

에칠알코올이 생체내의 산화, 환원반응을 촉매하는 보조효소인 NAD에 의해 산화되어 아세트알데하이드가 되며 환원된 NADH로 전환되는데 이와같은 전환에는 알코올로부터 히드리이온(H:)을 NAD로 전달하는 것이 필요하다. NAD는 히드리이온에 있는 전자쌍을 받아서 환원된다.Ethyl alcohol is oxidized by NAD, a coenzyme that catalyzes the oxidation and reduction reaction in vivo, becomes acetaldehyde and converted to reduced NADH. Such conversion requires the transfer of hydride (H :) from alcohol to NAD. Do. NAD receives and reduces the electron pair in the hydrion.

(과정 Ⅲ)(Course III)

이 반응은 NAD가 관여하는 에틸알코올의 산화 다음에 진행되는 것으로서 플라빈 모노 뉴클레오티드(FMN)도 알코올의 산화환원 반응에 관여하는 보조효소로서 작용하며 FMN의 환원제는 NAD의 환원형인 NADH이다. 따라서, FMN은 히드리이온을 받아 FMNH 로 환원되는 일련의 연속인 과정을 거쳐 알코올이 분해되어 대사되게 된다.This reaction is followed by oxidation of ethyl alcohol involving NAD. Flavin mononucleotide (FMN) also acts as a coenzyme involved in the redox reaction of alcohol, and the reducing agent of FMN is NADH, a reduced form of NAD. Therefore, FMN undergoes a series of continuous processes of receiving hydrion and reducing it to FMNH, whereby alcohol is decomposed and metabolized.

(과정 Ⅳ)(Course IV)

또다른 경로는 MEOS(microsomal ethanol oxida tion system)에서 이루어지며 MEOS는 세포의 소포체에 존재하는 물질로 이 마이크로솜 관련효소는 보조효소인 FAD와 FMN을 함유하고 있어 NADPH로부터 다양한 약품과 스테로이드 산화(steroid oxidation)에서 기능을 하는 마이크로솜 관련 시토크롬 P-450으로 전자를 전달해준다. 이 경로의 과정에서는 NADPH(니코틴아미드 아데닌 디 뉴클레오티드 포스페이트 환원형)-시토크롬 P-450의 환원효소는 NADPH-유도 지질의 과산화작용에 관여한다. 이들의 메커니즘은 NADPH의 산화과정중에 히드록시 라디칼이 형성되며 이 HO·가 지방과산화 작용의 개시 인자로서 O₂가 초과산화 음이온으로 환원되며 O₂는 수소 과산화물로 불 균등화(dismutase)된다.Another pathway is in the microsomal ethanol oxidation system (MEOS), which is a substance present in the endoplasmic reticulum of cells. This microsome-related enzyme contains the coenzymes FAD and FMN, which can lead to various drugs and steroid oxidation from NADPH. electrons are transferred to the microsomal cytochrome P-450, which functions in oxidation. In the course of this pathway, the reductase of NADPH (nicotinamide adenine dinucleotide phosphate reduced) -cytochrome P-450 is involved in the peroxidation of NADPH-induced lipids. Their mechanism is that hydroxy radicals are formed during the oxidation of NADPH, and this HO · is the initiation factor of fat peroxidation, and O2 is reduced to superoxide anion and O2 is dismutated to hydrogen peroxide.

(과정Ⅳ) Peroxysome에 존재하는 catalase 효소작용에 의한 분해과정(Process IV) Degradation Process by Catalase Enzyme Activity in Peroxysome

분자 산소의 환원에 의해 생성된 활성라디칼(superoxideradical -O₂)은 superoxide dismutase(SOD)에 의해 과산화수소(H2O2)로 되고, 다시 이물질은 카타라제(catalase)에 의해 Hydroxy radical(OH-)에 의해 물로 되며 또한 과산화수소는 glutathion peroxidase에 의해서도 물로 변한다.Active radicals produced by the reduction of molecular oxygen (H 2 O 2 ) are converted to hydrogen peroxide (S 2 O) by superoxide dismutase (SOD), and foreign substances are added to the hydroxyl radical (OH-) by catalase. Water is also converted to water by glutathion peroxidase.

따라서, 본 발명은 상기와 같은 사실에 의거한 것으로, 본 발명의 목적은 알코올 음용에서 생성되는 주요 독성물질인 아세트알데하이드 생성과정에서 소모된 NAD를 NADH로부터 빨리 재생시켜 줌으로써 알코올 분해를 촉진시킴은 물론 알코올 음용시 발생하는 다량의 활성산소를 극도로 억제시킴으로써 알코올성 장애를 보호해주는 naringin과 naringenin을 주요 유효성분으로 함유하는 알코올 대사촉진을 위한 건강음료조성물을 제공하는 것이다.Therefore, the present invention is based on the above facts, and an object of the present invention is to promote alcohol decomposition by quickly regenerating NAD consumed in the process of producing acetaldehyde, which is a major toxic substance produced in alcohol drinking, from NADH. It is to provide a health drink composition for promoting alcohol metabolism containing naringin and naringenin as the main active ingredients that protect alcoholic disorders by suppressing a large amount of free radicals generated during alcohol drinking.

본 발명의 조성물은 알코올 음용에서 생성되는 주요 독성물질인 아세트알데히드의 생성과정에서 소모된 NAD를 NADH로부터 빨리 재생시켜줌으로 해서 알코올분해를 촉진시킴은 물론, 알코올 음용시 발생되는 다량의 활성산소를 극도로 억제시킴으로써 알코올성 장애를 보호해주는 효과가 있다.The composition of the present invention promotes alcohol decomposition by quickly regenerating NAD consumed in the production of acetaldehyde, which is a major toxic substance produced in alcohol drinking, from NADH, as well as extremely high amounts of free radicals generated during alcohol drinking. By inhibiting the alcoholic disorders are effective in protecting.

구체적으로 설명하면, 알코올 음용전 30분 또는 음용후 30분 본 발명의 건강음료를 복용시킨후 알코올 음용으로 인한 알코올 농도의 감소 효과를 측정하기 위해 시간변화에 따른 호기중 알코올 농도의 변화를 측정함으로써 상기의 효과를 확인하였다. 이를 위해, 본 발명에서는 본 발명의 건강음료조성물을 투여한 군에서 시간 경과에 따라 호기중 알코올 잔류 농도의 시간 경과에 따른 감소 현상을 비교하였으며, 아울러 본 발명의 상기효과를 더욱 명백히 뒷받침하기 위하여 동물실험을 통하여 ADH 활성도, MEOS활성도, ALDH활성도 등을 확인하였다.Specifically, by measuring the change in alcohol concentration in exhalation with time change to measure the effect of reducing alcohol concentration due to alcohol drinking after taking the health drink of the present invention 30 minutes before or 30 minutes after drinking alcohol The above effect was confirmed. To this end, in the present invention in the group to which the health beverage composition of the present invention was administered compared with the time course of the decrease in the residual alcohol concentration in the air, and also to more clearly support the above effects of the present invention Through experiments, ADH activity, MEOS activity, ALDH activity, etc. were confirmed.

본 발명의 건강음료 조성물은 naringin과 naringenin을, naringin은 0.001-20중량%, naringenin은 0.001-10중량%를 더욱 좋게는 naringin 0.01-10중량%와 naringenin 0.01-5중량%을 함유하고, 여기에 아미노산 0.01-10중량%, 비타민류는 0.0001-5중량%, 미네랄류 0.0001-3중량%, 당류 0.01-20중량%, 유기산류 0.01-10중량%, 약용식물추출물 0.01-20중량% 및 기타 감미제, 향료 등을 첨가하여서 된 건강음료조성물이다.The health beverage composition of the present invention contains naringin and naringenin, naringin is 0.001-20% by weight, naringenin is 0.001-10% by weight, more preferably 0.01-10% by weight naringin and 0.01-5% by weight naringenin, 0.01-10% by weight of amino acids, 0.0001-5% by weight of vitamins, 0.0001-3% by weight of minerals, 0.01-20% by weight of sugars, 0.01-10% by weight of organic acids, 0.01-20% by weight of medicinal plant extracts and other sweeteners, It is a health drink composition made by adding fragrances.

본 발명의 구체적인 첨가예는 다음과 같다.Specific addition examples of the present invention are as follows.

첨가예 1.Addition Example 1.

naringin 또는 naringenin을 사이다와 같은 소프트 음료시럽에 용해하여 naringin 또는 naringenin을 각각 또는 그 혼합물로 하여 0.1-8중량% 함유하도록 제조한다.Naringin or naringenin is dissolved in a soft drink syrup such as cider and prepared to contain 0.1-8% by weight of naringin or naringenin, respectively, or as a mixture thereof.

첨가예 2.Addition Example 2.

각종 스포츠 드링크에 naringin 또는 naringenin을 각각 또는 그 혼합물로 하여 0.01-5중량% 함유하도록 제조한다.Various sports drinks are prepared so as to contain 0.01-5% by weight of naringin or naringenin, respectively or as a mixture thereof.

첨가예 3.Addition Example 3.

각종 과일, 야채류, 해조류, 콩, 천연약재등의 즙 또는 그 추출 농축액을 이용하여 제조한 음료에 naringin 또는 naringenin을 각각 또는 그 혼합물로 하여 0.1- 5중량% 함유하도록 제조한다.Naringin or naringenin is prepared to contain 0.1 to 5% by weight of each of the fruits, vegetables, seaweeds, soybeans, juices such as natural medicines or extracts thereof, and naringin or naringenin, respectively or as a mixture thereof.

첨가예 4.Addition Example 4.

피로회복제 음료에 naringin 또는 naringenin을 각각 또는 그 혼합물로 하여 0.1-3중량% 함유하도록 제조한다.It is prepared to contain 0.1-3% by weight of naringin or naringenin, respectively, or as a mixture thereof in the fatigue recovery beverage.

첨가예 5.Addition Example 5.

비타민 조제품에 naringin 또는 naringenin을 각각 또는 그 혼합물로 하여 0.1-2중량% 함유하도록 제조한다.The vitamin preparation is prepared so as to contain 0.1-2% by weight of naringin or naringenin, respectively or as a mixture thereof.

첨가예 6.Addition Example 6.

정제된 목초액 0.01-10중량%에 naringin 또는 naringenin을 각각 또는 그 혼합물로 하여 0.001-10중량% 함유하도록 제조한다.0.01-10% by weight of purified wood vinegar is prepared to contain 0.001-10% by weight of naringin or naringenin, respectively or as a mixture thereof.

참고실시예. Naringin의 추출방법 및 Naringenin의 제조방법Reference Example. Naringin Extraction Method and Naringenin Preparation Method

시중에서 구입한 건조된 최상품의 citrus arantium 1kg을 80 Mesh로 분쇄하여 3000ml의 증류수를 가하여 추출 여과한 후 40℃이하에서 감압하 500ml로 만든후 MeOH 1000ml를 가하여 수층을 분리한다. 수층을 감압증류하여 MEOH를 제거한후 다시 증류수를 가하여 500ml로 만든다. 여기에 AL-AC(aluminum acetate)를 가하여 90분간 진탕한다. 이것을 다시 감압 증류하여 정제수 1000ml를 가하여 2회 세척한후 여과하여 감압하 400ml가 되도록 증류한다. 400ml 원액에 N-부탄올(N-buthanol) 1000ml씩 가하여 3회 추출하고 감압하 380ml가 되도록 하여 여과한후 정제수1000ml씩을 가하여 2회 세척한후 여과한 여액을 감압하 350ml로 만든다. 여기에 활성탄 200g을 가하여 90분간 진탕한다. 여과하여 활성탄을 제거한후 여액을 감압증류 여과하여 300ml로 만든다.1kg of dried citrus arantium, commercially available, was pulverized into 80 mesh, extracted by filtration with 3000ml of distilled water, and made into 500ml under reduced pressure under 40 ℃, and 1000ml of MeOH was added to separate the aqueous layer. The aqueous layer was distilled under reduced pressure to remove MEOH, and then distilled water was added to make 500 ml. Add AL-AC (aluminum acetate) and shake for 90 minutes. This was distilled under reduced pressure again, 1000 ml of purified water was added thereto, washed twice, and then distilled to 400 ml under reduced pressure. 1000 ml of N-buthanol (N-buthanol) was added three times to extract 400 ml, and the mixture was filtered to give 380 ml under reduced pressure. After filtering twice with 1000 ml of purified water, the filtrate was filtered to make 350 ml under reduced pressure. 200 g of activated carbon was added thereto and shaken for 90 minutes. After filtration to remove activated carbon, the filtrate was distilled under reduced pressure to make 300 ml.

여액에 NH3SO(황산암모늄) 300g을 가한 다음 20분간 진탕한 후 24시간 방치한다. 생성 침전물을 여과한다. 여기에 70% ETOH 500ml를 가하여 50℃ 감압 증류한다. 1시간 방치후 불용분을 여과하여 제거한다. 감압증류하여 m.p 261℃의 무색 침상인 hesperidin 13.5g을 얻었다. 취득된 hesperidin중 7g에 증류수 350ml를 가하여 실온에서 24시간 방치한다.300 g of NH 3 SO (ammonium sulfate) is added to the filtrate, which is then shaken for 20 minutes and left for 24 hours. The resulting precipitate is filtered off. 500 ml of 70% ETOH was added thereto and distilled under reduced pressure at 50 ° C. After incubation for 1 hour, the insolubles are filtered off. Distillation under reduced pressure was carried out to obtain 13.5 g of hesperidin as a colorless needle at mp 261 ° C. To 7 g of the obtained hesperidin, 350 ml of distilled water is added and allowed to stand at room temperature for 24 hours.

여기에 IsoPropanol 100ml를 가하여 12시간 더 방치한다. 생성된 침강물을 감압하 증류여과하여 m.p. 83℃의 무색의 침상결정의 naringin 5.5g을 얻었다. 취득된 naringin에 2% H2SO4150ml로 가수분해하여 생성된 조결정을 50% EtOH로 재결정하여 감압하 증류하여 m.p. 248℃의 미황색 침상 결정의 naringenin 3g을 얻었다.Add 100 ml of IsoPropanol and leave for 12 hours. The resulting precipitate was distilled off under reduced pressure to obtain 5.5 g of naringin as a colorless acicular crystal at mp 83 ° C. Crude crystals formed by hydrolysis of the obtained naringin with 150 ml of 2% H 2 SO 4 were recrystallized with 50% EtOH and distilled under reduced pressure to obtain 3 g of naringenin as a pale yellow acicular crystal at mp 248 ° C.

① 재료, 기기 및 시약① Materials, instruments and reagents

실험에 사용한 재료는 citrus aurantium(광귤)의 과피를 사용하였으며, 용매제로는 추출시 주로 많이 활용하고 있는 methanol ,ethtylacetate, aluminium acetate, 무수 ethanol, isopropanol, 황산, 황산염, N-부탄올을 사용.The material used for the experiment was citrus aurantium skin, and solvent, methanol, ethtylacetate, aluminum acetate, anhydrous ethanol, isopropanol, sulfuric acid, sulfate, and N-butanol.

② 표준품 : naringin, naringenin.-sigma.co② Standard Products: naringin, naringenin.-sigma.co

③ 기기로는 원심분리기, 감압증류기, HPLC.auto clab.③ Instruments include centrifuge, vacuum distillation, HPLC.auto clab.

이에, 다음의 실시예를 들어 본 발명을 보다 상세히 설명한다.Thus, the present invention will be described in more detail with reference to the following examples.

실시예 1. 알코올음용실험Example 1 Alcohol Drinking Experiment

1)실험재료 및 방법1) Experimental Materials and Methods

(1)실험대상: ①남성(20세-25세의 평균체중 65kg) 20 명(특정병력이 없으며 간기능 검사상 아무 이상이 없는 지원자)(1) Subjects: ① Male (average weight 65kg for 20-25 years old) 20 people

②여성(20세-25세의 평균체중 55kg) 5 명( ' )② Women (average weight 55kg from 20 to 25 years old) 5 people (')

(2) 실험재료:(2) Experimental materials:

1) 사용알코올 : 알코올 40%의 위스키(johny walker black label)1) Alcohol: 40% alcohol whiskey (johny walker black label)

2) 투여조성물: 본 발명자의 조성물: 100ml수용액2) Dosage composition: Composition of the inventor: 100ml aqueous solution

※정제수 100ml당 naringin과 naringenin등이 첨가된 조성물 함량을 나타냄.※ It shows the composition content of naringin and naringenin added per 100ml of purified water.

(3) 실험방법: 호기중 알코올농도 : 적외선식 호기알코올분석법에 의함(3) Experimental method: alcohol concentration in aerobic: by infrared breath alcohol analysis

2).실험내용2) .Experiment

실험조사를 위해 남성은 40。 위스키 150-200ml씩을(30분에서 60분 사이에 음용) 여성은 40。 위스키 50-80ml씩을(30분에서 60분 사이에 음용) 각 5군(가.나.다.라.마군)으로 분류 각군 5명에게 음용케 한 뒤 시간의 변화에 따른 호기중 알코올 농도를 측정하였다.For the purpose of the experiment, males consume 150-200ml of 40 ° whiskey (drinking between 30 and 60 minutes) and females consume 50-80ml of 40 ° whiskey (drinking between 30 and 60 minutes). C. Group 5) After each group was drinked, the concentration of aerobic alcohol with time was measured.

(가)군: 알코올을 섭취하고 100ml의 정수된 물의 투여군.(A) group: A group of ingesting alcohol and administering 100 ml of purified water.

(나)군: 알코올음용후 본 발명조성물 실시예 (나)군의 투여군.(B) group: administration group of the present invention composition Example (B) group after alcohol drinking.

(다)군: 알코올음용후본발명조성물실시예(다)군의 투여군(C) group: administration group of the present invention composition after alcohol drinking (C) group

(라)군: 알코올음용후본발명조성물실시예(라)군의 투여군(D) group: administration group of the present invention composition after alcohol drinking (D) group

(마)군: 알코올음용후본발명조성물실시예(마)군의 투여군(E) group: administration group of the present invention composition (e) group after alcohol drinking

3)실험결과 고찰3) Examination results

(0*)은 대조군(가)를 기준으로 한 호기중 알코올 억제율(%)(0 * ) is the percentage of aerobic alcohol inhibition in the control group (a)

※유의도(P<0.005, n=5)※ Priority (P <0.005, n = 5)

적외선식 호기 알코올 분석법에 의한 실험 결과를 고찰해 보면,Considering the experimental results by infrared breath alcohol analysis,

1).실험결과1) .Experiment result

①대조군 ㉮군(알코올음용과 동량의 정제수 100ml를 투여한군), ㉯군(naringin 50mg이 첨가된 100ml 용량의 본 조성물 투여군)의 실험 측정 결과 1시간후에는 ㉮군의 호기중 알코올 농도는 0.32mg으로 나타났으나, ㉯군은 0.175mg까지 감소되어 약 45.3%이하의 억제효과를 보였다. 2시간 후에는 ㉮군 0.26mg, ㉯군 0.175mg으로 비교 결과는 약 32.7%이하의 억제효과를 나타냈다. 이 억제 효과는 4시간 후까지 지속되어 ㉮군, ㉯군의 비교는 약 4.3%이하의 억제 감소 효과를 보였다.① As a result of the experimental measurement of the control group (group treated with 100ml of alcohol and drinking the same amount of purified water) and group (group administered with 100 ml of this composition with 50 mg of naringin), the alcohol concentration in the aerobic group was 0.32mg after 1 hour. However, the ㉯ group decreased to 0.175mg, showing an inhibitory effect of less than about 45.3%. After 2 hours, the group showed 0.26mg of group V and 0.175mg of group V. The comparison result showed less than 32.7% of inhibition effect. The inhibitory effect lasted up to 4 hours, and the comparison of group V and group showed less than 4.3% of inhibition.

②대조군 ㉮군과 비교군 ㉰군(naringin 100mg이 첨가된 100ml 용량의 조성물 투여군)과의 비교 실험의 경우 1시간후 0.32mg/0.17mg로 감소되어 약46.9% 이하의 억제 효과를 보였으며, 2시간 후에는 26mg/17mg으로 감소되어 약 34.6% 이하의 억제 효과를 보였다. 4시간후(약4.2%이하까지 억제) 까지 그 효과가 지속되었다.② In the comparative experiment with the control group 비교 group and the control group 조성물 group (administration group of a 100ml dose of naringin 100mg added), after 1 hour was reduced to 0.32mg / 0.17mg showed an inhibitory effect of less than about 46.9%, 2 After time, it was reduced to 26 mg / 17 mg, showing an inhibitory effect of less than about 34.6%. The effect lasted until 4 hours (up to about 4.2% or less).

③음주후의 대조군 ㉮군과 비교군 ㉱군(naringenin 50mg이 첨가된 100ml 용량의 조성물 투여군)의 시간별 감소 및 억제효과는 1시간후 0.32mg/0.18mg이 되어 약 43.8% 이하의 억제효과를 보였다. 또한, 2시간 후에는 ㉮군과 ㉱군의 비교 감소 및 억제 효과는 0.26mg/0.18mg로 약 30.8% 이하로 나타났으며, 4시간 후에는 3.3% 이하의 억제 효과의 지속성을 보였다.③ After the drinking time, the control group 비교 group and the control group ㉱ group (group 100ml composition addition group with naringenin 50mg) was reduced and suppressed by hourly 0.32mg / 0.18mg showed an inhibitory effect of about 43.8% or less. In addition, after 2 hours, the comparative reduction and inhibition effect of group V and group V was 0.26 mg / 0.18 mg, which was about 30.8% or less, and after 4 hours, the inhibition effect was 3.3% or less.

④음주후의 대조군 ㉮군과 비교군 ㉲군(naringin 50mg과 naringenin 50mg이 첨가된 100ml 용량의 조성물 투여군)의 시간별 감소 및 억제효과는 1시간후0.32mg/0.165mg이 되어 약 48.4% 이하의 억제효과를 보였으며, 2시간후의 측정 결과는 0.26mg/0.165mg이 되어 약 36.5% 이하의 억제효과를 나타냈다. 4시간이 지난후의 억제효과는 0.12mg/0.108mg으로 감소되어 약 11.7%이하 까지 억제효과가 지속되었다.④ After 1 hour, the control group 비교 group and the control group 비교 group (group 100ml composition of naringenin 50mg and naringenin 50mg added) and reduction and inhibition effect over time was 0.32mg / 0.165mg after 1 hour to suppress the inhibition of about 48.4% After 2 hours, the measurement result was 0.26mg / 0.165mg, showing an inhibitory effect of less than about 36.5%. After 4 hours, the inhibitory effect was reduced to 0.12mg / 0.108mg, and the inhibitory effect continued to below 11.7%.

이번의 실험결과로 얻은 수치는 naringin과 naringenin을 주요 유효 성분으로 함유한 본 발명 조성물의 알코올대사촉진 효과가 우수함을 입증할 수 있었으며, naringin과 naringenin과의 생리활성 효과는 알코올의 대사촉진효과에서만 본다면 naringin이 naringenin에 비해 약간 우수함을 보여주었다. 또한, naringin과 naringenin을 혼합하여 첨가된 조성물이 naringin과 naringenin을 각각 단독으로 하여 첨가된 조성물 보다 알코올 대사 촉진면에서 더 좋은 효과를 보여주었다.The results obtained in this experiment can prove that the alcohol metabolism promoting effect of the composition of the present invention containing naringin and naringenin as the main active ingredient, the physiological activity effect of naringin and naringenin only if the metabolic promoting effect of alcohol naringin was slightly superior to naringenin. In addition, the composition added by mixing naringin and naringenin showed better effect in promoting alcohol metabolism than the composition added by naringin and naringenin alone.

실시예 2. 동물실험Example 2. Animal Experiment

1)재료 및 방법1) Materials and Methods

본 실험에 사용한 웅성 스프레이그-둘리게 흰쥐는 조선대학교 약학대학 동물실험실에서 이유후 30마리를 분양받았으며 체중 200-300g 정도 되도록 사육한 다음 실험에 임하였다. 본 실험에 이용한 각종 시약은 고급품의 분석용시약을 구입 사용하였다.The male Sprague-Dudley rats used in this experiment were fed after weaning in the animal laboratory of Chosun University College of Pharmacy. Various reagents used in this experiment were purchased from a high quality reagent for analysis.

※;기본식이와 조성물을 정제수를 용매로 하여 100mg/ml 농도로 조제한 후 흰쥐 체중 10g당 0.1ml씩 매일 경구투여(투여기간:8주간)※; The basic diet and composition were prepared at 100mg / ml concentration using purified water as a solvent, and then oral administration daily at 0.1ml per 10g of rats (during 8 weeks).

대조군 A(10마리)에는 본 발명의 조성물을 투여하지 않은 대신 sucrose를 0.02% 더 투여된 기본 식이를 섭취시켰으며, 비교군 B(10마리)에는 기본식이에 naringin 50mg이 첨가된 조성물 0.02%를 추가 투입한 식이를 섭취시켰으며, 비교군 C(10마리)에는 기본식이에 naringenin 50mg이 첨가된 조성물 0.02%를 추가 투입한 식이를 섭취시켰다. 이들 각군들을 8주간 사육하였다. 세 그룹의 흰쥐들에게 섭취시킨 식이의 조성물은 표 4에 나타나 있다.In control group A (10 animals), instead of administering the composition of the present invention, a basic diet containing 0.02% more sucrose was consumed. In comparison group B (10 animals), 0.02% of a composition containing 50 mg of naringin was added to the basic diet. An additional diet was ingested, and a comparison group C (10 animals) was fed a diet supplemented with 0.02% of a composition containing 50 mg of naringenin added to the basic diet. Each group was raised for eight weeks. The dietary composition of the three groups of rats is shown in Table 4.

A, B, C군에 각각 25%의 에탄올을 체중 2.5g/kg씩 1일 1회 구강 투여하였다. 각각 8주간 사육한 흰쥐를 10시간 절식 시킨후 즉시 흰쥐를 희생시키고 간 3g을 세절하고, 7배 부피의 0.25M 설탕 용액을 첨가하여 균질기를 빙냉하에서 마쇄하여 얻은 균질액(20%,w/v) 600g에서 10분간 원심분리하여 상징액을 얻어 10,000g에서 20분간 원심분리하고, 미토콘드리아 분획을 분리후 다시 105,000g에서 60분간 초원심분리하여 사이토졸 분획과 마이크로소옴 분획을 분리하고, 효소 활성 측정시 효소원으로 사용하였다. 효소활성은 bovin serum albumin을 표준품으로 하여 Lowry 법에 준해 측정한 단백질 mg당 고유활성도를 측정하였다.A, B and C groups were orally administered once daily with 25% of ethanol at a weight of 2.5 g / kg. After 8 hours of fasting, the rats were sacrificed for 10 hours, and the rats were sacrificed immediately, and 3 g of liver was chopped, and the homogenate obtained by grinding the homogenizer under ice-cooling with the addition of a 7-fold volume of 0.25M sugar solution (20%, w / v). ) Centrifuged at 600g for 10 minutes to obtain supernatant, centrifuged at 10,000g for 20 minutes, and after separation of mitochondrial fraction, ultracentrifugation at 105,000g for 60 minutes to separate cytosol fraction and microsomal fraction. Used as an enzyme source. Enzyme activity was measured by intrinsic activity per mg of protein measured according to the Lowry method using bovin serum albumin as a standard.

2)시료의 분석2) analysis of samples

-ADH(Alcohol dehydrogenase)활성: Bergmeyer의 방법에 의함.-ADH (Alcohol dehydrogenase) activity: by Bergmeyer's method.

-MEOS(microsomol ethanol-oxidizing system)활성: Liber와 Decarli방법 채용-MEOS (microsomol ethanol-oxidizing system) activity: adopt Liber and Decarli method

-ALDH(aldehidedehydrogenase)활성: koivula&koivusalo의 방법에 의함-ALDH (aldehidedehydrogenase) activity: by the method of koivula & koivusalo

※유의도 (P<0.005.N;10)※ Degree of Intention (P <0.005.N; 10)

※통계처리: 실험결과는 SAS package를 이용하여 실험군당 평균±표준편차로 표시하였고, 각 군간의 평균치의 통계적 유의성은 P<0.005수준에서 Duncan's multiple test에 의해 검정되었다.Statistical treatment: The experimental results were expressed as mean ± standard deviation per experimental group using SAS package, and statistical significance of mean value between groups was tested by Duncan's multiple test at P <0.005 level.

3)결과고찰3) Review of results

① ADH활성은 B, C군에 비해 A군이 유의한 증가를 보였고, B군보다, C군이 증가된 활성을 보였다.① ADH activity was significantly increased in group A compared with group B and C, and group C showed higher activity than group B.

② ADH 는 알코올을 아세트알데히드로 산화시키는 효소로서 급성의 경우 아급성 중독시에 비해 활성도가 높으며, 알코올의 장기 투여시 간 자체의 변성으로 활성이 감소되어서 다른 알코올 대사계인 MEOS에 의해 알코올대사가 이루어진다. 본 실험 결과는 알코올의 아급성 중독 상태의 흰쥐에서 ADH활성이 증가되었다. 따라서, 본 발명의 건강음료조성물이 알코올 투여시 간에서의 ADH의 활성을 조절하여 알코올대사계를 더욱 활성시킴으로써 알코올 해독에 관여한 것으로 보아진다. 간의 MEOS활성은 A군에 비해 B군과 C군이 유의한 감소를 보였다.② ADH is an enzyme that oxidizes acetaldehyde into alcohol. In case of acute, it has higher activity than subacute poisoning, and its metabolism is reduced due to the degeneration of alcohol itself by long-term administration of alcohol. . The results showed that ADH activity was increased in rats with alcoholic subacute intoxication. Therefore, it is believed that the health beverage composition of the present invention is involved in alcohol detoxification by regulating the activity of ADH in the liver during alcohol administration to further activate the alcohol metabolism system. Hepatic MEOS activity was significantly decreased in group B and C compared to group A.

③ ALDH의 활성은 A군에 비하여 B, C군이 유의하게 증가되었다.③ The activity of ALDH was significantly increased in B and C groups compared to A group.

이러한 결과로 볼 때, 본 조성물은 알코올성 장애로 인한 대사의 부조화를 효과적으로 조절할 수 있는 물질이며, 아울러 항산화(ANTIOXIDANT) 대사성 생리활성 조성물임을 알 수 있다.From these results, the present composition is a substance that can effectively control the mismatch of metabolism due to alcoholic disorders, it can be seen that the antioxidant (ANTIOXIDANT) metabolic bioactive composition.

본 발명의 조성물은 알코올음용에서 생성되는 주요 독성물질인 아세트알데히드의 생성과정에서 소모된 NAD를 NADH로부터 빨리 재생시켜줌으로 해서 알코올분해를 촉진시킴은 물론, 알코올 음용시 발생되는 다량의 활성산소를 극도로 억제시킴으로써 알코올성 장애를 보호해주는 효과가 있다. 또한, 본 발명의 조성물은 알코올 투여시 간에서의 ADH의 활성을 조절하여 알코올대사계를 더욱 활성화시킴으로써 알코올성 장애로 인한 대사의 부조화를 효과적으로 조절할 수 있고, 아울러 항산화(ANTIOXIDANT) 대사성 생리활성 조성물로도 매우 유용하다.The composition of the present invention promotes alcohol decomposition by quickly regenerating NAD consumed in the production of acetaldehyde, which is a major toxic substance produced in alcohol drinking, from NADH, as well as extreme amounts of free radicals generated during alcohol drinking. By inhibiting the alcoholic disorders are effective in protecting. In addition, the composition of the present invention can effectively control the metabolic mismatch caused by alcoholic disorders by further activating the alcohol metabolism by regulating the activity of ADH in the liver during alcohol administration, and also as an antioxidant (ANTIOXIDANT) metabolic bioactive composition Very useful.

Claims (4)

삭제delete 나린진 및 나린게닌을 각각 또는 그 혼합물을 유효성분으로 0.001 ∼ 10 중량% 함유하고, 나린진 또는 나린게닌을 각각 또는 혼합환산하여 하루에 0.0001-0.2g/kg 체중의 양으로 사용함을 특징으로 하는 알코올대사촉진을 위한 건강음료조성물.Alcohol metabolism, characterized in that it contains 0.001 to 10% by weight of naringin and naringenin, respectively, or a mixture thereof as an active ingredient, and the amount of naringin or naringinin, respectively, or in the amount of 0.0001-0.2g / kg body weight per day. Health drink composition for promotion. 삭제delete 제 2항에 있어서, 발효 정제된 목초액 0.01-10중량%를 추가로 함유하는 것을 특징으로 하는 알코올대사촉진을 위한 건강음료조성물.The health beverage composition for alcohol metabolism promotion according to claim 2, further comprising 0.01-10% by weight of fermented and purified wood vinegar.
KR10-2000-0002813A 2000-01-21 2000-01-21 Health beverage containing naringin and naringenin used for acceleration of alcohol metabolism KR100375047B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2000-0002813A KR100375047B1 (en) 2000-01-21 2000-01-21 Health beverage containing naringin and naringenin used for acceleration of alcohol metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0002813A KR100375047B1 (en) 2000-01-21 2000-01-21 Health beverage containing naringin and naringenin used for acceleration of alcohol metabolism

Publications (2)

Publication Number Publication Date
KR20010075892A KR20010075892A (en) 2001-08-11
KR100375047B1 true KR100375047B1 (en) 2003-03-08

Family

ID=19640256

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-0002813A KR100375047B1 (en) 2000-01-21 2000-01-21 Health beverage containing naringin and naringenin used for acceleration of alcohol metabolism

Country Status (1)

Country Link
KR (1) KR100375047B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190025288A (en) 2017-09-01 2019-03-11 (주)지에프씨생명과학 Cosmetics Composition Containing Compounds Having Anti-oxidant, Anti-inflammatory and Anti-wrinkle Derived from Hwangsook-jong

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030037885A (en) * 2001-11-07 2003-05-16 최명숙 Composition for elimination of hangover containing naringin
KR100500840B1 (en) * 2003-04-30 2005-07-12 학교법인고려중앙학원 A method for purifying naringenine from citron and the use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190025288A (en) 2017-09-01 2019-03-11 (주)지에프씨생명과학 Cosmetics Composition Containing Compounds Having Anti-oxidant, Anti-inflammatory and Anti-wrinkle Derived from Hwangsook-jong

Also Published As

Publication number Publication date
KR20010075892A (en) 2001-08-11

Similar Documents

Publication Publication Date Title
KR101183605B1 (en) The beverage composition for anti-hangover functional using cucumber vinegar
Lieber The metabolism of alcohol
US5547671A (en) Anti-intoxication composition
JPH07500316A (en) Methods of inhibiting ALDH-I useful in treating alcohol dependence or alcohol abuse disorder
KR101301094B1 (en) Composition for relieving hangover or improving liver function
CN101775347A (en) Health-care vinegar, vinegar drink preparation method and anti-alcohol liver-protection application thereof
CN102038260A (en) Chinese medicinal alcoholism relieving health-care beverage and preparation method thereof
Massie et al. Dietary vitamin C improves the survival of mice
CN103445175B (en) Composition with effects of alleviating hangover and protecting liver
KR101271765B1 (en) Preparation method of Makgirlli with the reducing effect of hepatic damage and hangover produced by chronic drinking
CN110123952A (en) A kind of anti-alcoholism liver protecting compound preparation and its application
GB2198041A (en) Inhibiting alcohol addiction
KR100375047B1 (en) Health beverage containing naringin and naringenin used for acceleration of alcohol metabolism
KR20150088671A (en) Hangover recovery drink using bean sprouts and manufacturing method thereof
JP2010059104A (en) Xanthine oxidase inhibitor
CN111066994A (en) Functional beverage for dispelling effects of alcohol and protecting liver and preparation method thereof
KR20180019845A (en) Composition for Treating Hangover Comprising Extract of Protaetia Orientalis Larva and Hovenia Dulcis Fruit
JPH07285881A (en) Excitometabolic agent for alcohol
JP2006241108A (en) Cell activator
US20070031520A1 (en) Method of using ajoene as alcohol dehydrogenase inhibitor, composition for removing hangover comprising ajoene and method of preparing the same
KR20080092045A (en) The food break up hangover
KR101655882B1 (en) Composition for eliminating hangover comprising exopolysaccharide produced by ceriporia lacerata as an active ingredient
KR101725261B1 (en) Composition for the dissolving of the alcohol consistencies in blood and the neutralizing poisons of the hangover
KR101168673B1 (en) Soju containing chitosan and preparing method thereof
EP3357541B1 (en) Methylsulfonylmethane composition for reducing blood alcohol content

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
N231 Notification of change of applicant
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110523

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee